Investors Economics Commentary Forex Politics Entertainment Content Sales Search   Advanced Search
LATEST NEWS
 
 
News
 Latest Headlines
 Quick Facts
 Breaking News
 Top Stories
 Earnings News
 Feature Articles
 Politics
 US Policy
 General
 Commodities
 Canadian
 UK
 Indian
 Wallstreet Events
 Slide Shows
 US Economic News
 European Economic News
 Asian Economic News
 All Economic News
 FX Top Stories
 Currency Alerts
 Mkt Sensitive News
 Politics
 European Mkt Updates
 Asian Mkt Updates
 Treasury Mkt Updates
 Pop
 Rock
 Classic Rock
 Rap/Hip-Hop
 Country
 Alternative
 Oldies
 Movie Reviews
 DVD Releases
 Box Office
 Slide Shows
 Business News
Commentary/Analysis
 Daily Market Analysis
 US Market Updates
 US Commentary
 Asian Commentary
 European Commentary
 Canadian Commentary
 Indian Commentary
 Sector/Market Trends
Stock Alerts
 Stocks To Watch
 Long Term Stocks
 Before the Bell
 $5 and Under
 After the Bell
 Intraday Updates
 IPOs
 Hot Stocks
Earnings Calendars
 Upcoming Earnings
 Latest Earnings
 Pos Pre Announcements
 Neg Pre Announcements
Corporate Calendars
 Stock Splits
 Stock Buybacks
 Dividends
 Conference Calls
 FDA Calendar
 Board Meetings
 Mergers & Acquisitions
Ratings Changes
 Upgrades
 Downgrades
 Coverage Initiations
 Coverage Reiterated
 All Videos
 Market Commentary
 Top Stories
 Economic News
 Political News
 Foreign Markets
 Corporate News
 Entertainment News
 Top Stories
 Earnings
 Mergers & Acquisitions
 Market Commentary
 Economic News
 IPOs and New Issues
 Corporate News
 Forex News
 Interviews
 Private Equity
Economic Calendar
RTT DeskAlert
Mobile 

Follow Us
RTTNews on Twitter RTTNews on Facebook RTTNews on MySpace RTTNews on YouTube


Teva Pharmaceutical Industries Set New 52-Week High Thursday
3/19/2010 9:01 AM ET
RELATED NEWS
Teva Pharmaceutical Investor Meeting At 1:00 PM ET
Teva Pharmaceutical Has Risen To Another New High
Teva Pharmaceutical To Webcast Of Investor Meeting; Webcast At 1:00 PM ET
Teva Rises On Winning Bidding War For Ratiopharm - Update
Teva To Acquire Germany's Ratiopharm For 3.625 Bln Euros - Update

Trade TEVA now with
TOP MARKET NEWS
Discounted Them Crooked Vultures On Sunday
Stocks Post Moderate Losses Amid Slew Of Market Concerns - U.S. Commentary
AARP, AMA Call For Passage Of Health Care Reform Bill
Stocks Stuck In Negative Territory In Mid-Afternoon Trading - U.S. Commentary
Obama Holds Rally In Support Of Health Care Reform
(RTTNews) -  Teva Pharmaceutical Industries (TEVA: News ) announced Thursday morning that it entered into a definitive agreement to acquire ratiopharm for an enterprise value of €3.625 billion. Teva expects to complete the transaction by year-end 2010.
Teva Pharmaceutical gapped open sharply higher Thursday, but was range-bound for the majority of the session. The stock closed up by $2.07 at $62.01 on strong volume. Teva climbed past the upper end of a 2 1/2 week range and set a new high for the year.

Click here to receive FREE breaking news email alerts for Teva Pharmaceutical Industries Ltd and others in your portfolio

by RTT Staff Writer

For comments and feedback: contact editorial@rttnews.com

Email        Print           Follow Us RTTNews on Facebook RTTNews on MySpace RTTNews on YouTube


More Before the bell
11  Finisar Set New High For Year Thursday
10  ResMed Finished At Third Consecutive New 52-Week High Thursday
DineEquity Closed At Fifth Consecutive New 52-Week High Thursday
China-Biotics Set New High For Year Thursday
Boeing Set New 52-Week High Thursday
United Parcel Service Finished Thursday At New High For Year
FedEx Set New High For Year
Bed Bath & Beyond Closed Thursday At New High For Year
Nike Finished At Second Consecutive New High For Year Thursday
CRA Sank To Over Five-Month Low Thursday
Somaxon Pharmaceuticals Closed At New High For Year Thursday
11 Articles
  

 

Copyright © 2010 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service.

Feedback| Terms of Service| Advertise| Privacy| Buy Content | RSS | Mobile